Study Group: Economic Experts on Formulary Designs (US)
Council Members in this Study Group: 51
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
- Carrie Harris-Muller
Chief Administrative Officer
KAISER FOUNDATION HOSPITALS INC
Carrie Harris-Muller is the Chief Administrative Officer of Kaiser Permanente in the Mid-Atlantic States. Previously, Ms. Harris-Muller served as the Regional Vice President of HealthPlan Administration and Contracting. She has held several executive...
Dea BelaziPharmacy Consultant
Dea Belazi, PharmD, MPH, PAHMDea Belazi, PharmD, MPH, PAHM, is currently a Consultant working with health plans and pharmaceutical companies. Dr. Belazi is also a Consulting Practice Leader for Wolters Kluwer Health- Managed Care Group. Previously, he was the Senior Director of Pharmacy...
Steven MillerPresident
Steven Miller, MS, DPHSteven Miller, MSPharm, DPH, is the President and Chief Executive Officer of SJM Enterprises, a multi-faceted consumer-response organization, specializing in workers compensation, medication therapy management, and managed care pharmaceutical reimbursement...
Tim GallagherExecutive Vice President of Pharmacy Operations
ASTRUP DRUG, INC.Tim Gallagher, RPh, is the Executive Vice President of Pharmacy Operations at Astrup Drug in Minnesota, since 1999. Mr. Gallagher manages all aspects of pharmacy operations for the company. He has been a practicing pharmacist for over 25 years in both...
- William Fink
President
Managed Care Pharmacy Consultants, IncWilliam Fink, RPh, is the President of Managed Care Pharmacy Consultants in Tucson, Arizona. He has been active in managed care pharmacy for over 25 years. Mr. Fink's expertise includes managing pharmacy and clinical programs for HMOs (including Medicare...
GLG NewsSM Analyses by this Study Group's Leading Experts(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
August 28, 2008
Analysis by: William Fink, President,Dr. Mark Yergin testifies to Congress | www.nytimes.com
Doctors must be educated on the correct use of Methadone if unnecessary deaths are to be avoided.
-
Trends for Chronic Kidney Disease (CKD)
June 26, 2008
Analysis by: William Fink, President,Resource Article: “Chronic Kidney Disease Prevalence Increases, Awareness Remains Low,” Drug Benefit Trends (vol. 20, no. 5, May 2008) | jama.ama-assn.org
There will be an increased use of costly diaylsis, especially among those people 70 years or older. One would think that there would be a greater awareness of a disease consting $31 billion dollars a year. However, this does not seem to be the case.
-
May 6, 2008
Analysis by: William Fink, President,DXA Reimbursement Reductions: Implications for Quality Osteoporosis Care, Marjorie Luckey, MD and Roberta Biegel (Washington, DC: National Osteoporosis Foundation, Winter 2005) | osteoporosisblogger.com
It is well known that millions of people in the US suffer from osteoporosis which leads directly to debilitating fractures. Early diagnosis of osteoporosis and low bone mass will help prevent chronic pain and loss of independence. Once diagnosed, treatment is readily available and effective. DXA of the hip and spine (central DXA) is the imaging procedure recommended for this diagnosis and monitoring for the effectiveness of treatment. However, without legistative action, patient access to the central DXA may be compromised.
-
January 28, 2008
Analysis by: Dea Belazi, Pharmacy Consultant,FDA Receives New Data on Risks of Anemia Drugs | www.fda.gov
Increased FDA warnings on ESAs, suchas Epogen, Procrit and Aranesp will provide payers the ability to further restrict these agents. Restrictions will come in the form of prior authorizations and other utilization management techniques.
-
Should We Treat Colds In Children?
November 1, 2007
Cough-Medicine Dilemma Widens | online.wsj.com
An FDA advisory panel recently voted to stop the recommendation of otc cough and cold products in children less than 12 years of age. For decades parents have administered otc cough and could products to infants and young children. Even the FDA Advisory Committee had dissention amongst their members, voting 13 to 9 in favor of the change in the long standing treatment protocol of children's colds.
Members in this Study Group include these company types:
- Managed Care Health Insurer, For-Profit
- Pharmaceutical Benefits Manager, Small <10 M Lives
- Blue Cross/Blue Shield Non-Profit Health Insurer
- Managed Care Health Insurer, Non-Profit
- Consultancy, Pharma-Focused
- Healthcare Management
- Pharmacy or Drug Store, Chain
- Facility, Academic Medical Center
- Academic Medical Center/Hospital or Clinic
- Non-Academic Community Hospital or Clinic
- Other Freestanding Healthcare Facility
- Pharmaceutical Benefits Manager, Large >10 M Lives
Members in this Study Group often have these job titles:
- Pharmacist - RPh/PharmD
- Director
- Medical Director
- Manager
- President
- Operations Executive
- Owner
Related Study Groups
| Study Group Name | No. Members |
|---|---|
| Formulary Design Experts | 250 |
| Generic Drug Economic Experts | 766 |
| Economic Experts on Managed Care | 714 |
| Pharmacists (US) | 2077 |
| Managed Care Experts | 669 |
| Experts on Generic Pharmaceuticals: Pharmacists | 106 |
| Medicare Experts | 493 |
| Zocor Pricing Experts (US) | 38 |
GLG Live Meetings with this Study Group's Leading Experts (?)
July 31, 2007 | Boston
GLGi: Managed Care FormularyJuly 30, 2007 | New York
GLGi: Managed Care FormularyGLG Webcasts & Teleconferences
Leading Experts in Economic Experts on Formulary Designs (US) have not participated in any GLG webcasts.